Clinical Trial Update: Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects [Phase 2]

View source ↗

Summary

Phase II clinical trial of SHR2554 tablets in combination with other anti-tumor treatments for locally advanced or metastatic non-small cell lung cancer is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SHR2554

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Locally Advanced or Metastatic Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING